Burney Company’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Burney Company’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,739	Closed	-$309K	–	458
2017 Q4	$309K	Buy	+5,739	New	+$314K	0.02%	339
2017 Q2	–	Sell	-3,760	Closed	-$205K	–	415
2017 Q1	$205K	Buy	+3,760	New	+$185K	0.01%	373

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Burney Company's BIVV Position: Q1 2018 in Review

Burney Company sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 5,739 shares — an estimated $309K sold.

Burney Company first reported a position in BIVV in Q1 2017 and held it in 2 quarters. The position peaked at $309K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Burney Company reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Burney Company sold 5,739 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $309K.
Burney Company first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 2 quarters.
Burney Company's Bioverativ Inc. Common Stock position peaked at $309K in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Burney Company's 13F filing for Q1 2018, filed 8 May 2018.